No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SPRY ARS Pharmaceuticals
- 11.410
- +0.210+1.88%
Close Dec 24 13:00 ET
- 11.360
- -0.050-0.44%
Post 17:01 ET
1.11BMarket Cap-22.82P/E (TTM)
11.465High11.020Low497.58KVolume11.160Open11.200Pre Close5.62MTurnover1.08%Turnover RatioLossP/E (Static)97.19MShares18.51052wk High5.52P/B524.64MFloat Cap5.19052wk Low--Dividend TTM45.98MShs Float63.410Historical High--Div YieldTTM3.97%Amplitude2.550Historical Low11.287Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Institutional Owners May Ignore ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) Recent US$67m Market Cap Decline as Longer-term Profits Stay in the Green
ARS Pharmaceuticals Says Express Scripts Has Added Neffy (Epinephrine Nasal Spray) To Its Commercial National Formularies
ARS Pharmaceuticals Announces Neffy (Epinephrine Nasal Spray) Is Available on Express Scripts Commercial National Formularies
ARS Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia
ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)
Heat List
US
Overall
Symbol
Price
% Chg
No Data